Back to search

Article

Establishment of a second-generation transgenic marmoset model of polyglutamine disease recapitulating neurological symptoms and pathology

2025-03-13

Abstract excerpt

Neurodegenerative diseases, including polyglutamine diseases, remain a major clinical challenge, partly because of limited animal models that recapitulate human disease. Here, we describe a second-generation transgenic marmoset model of spinocerebellar ataxia 3 (SCA3), a polyglutamine disease, which stably expresses expanded CAG repeats in ATXN3 . All five offspring of the founder marmoset harbored the transgene...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b6b2bf42-e879-5be6-a9e3-4231140d0d6f
DOI
10.1101/2025.03.12.642922
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Establishment of a second-generation transgenic marmoset model of polyglutamine disease recapitulating neurological symptoms and pathologyDOI 10.1101/2025.03.12.642922
Select a neighboring publication to make it the new centre.